Moderna target price raised to $200 from $95 by Morgan Stanley
MRNA•Morgan Stanley raised its target price for Moderna to $200 from $95.
Related News

Envue Medical delays third-quarter report to complete financial review
FEED•

Ur-Energy starts baseline studies at Lost Soldier uranium project
URG•

Citigroup raises GXO Logistics target price to $71 from $66
GXO•

Wells Fargo raises Intuit target price to $330 from $300
INTU•

US reportedly to ease pension rules for investment firms linked to misconduct
XLF•